Pharmacological investigations of berberine sulphate.
D000562:Amebiasis / Q000188:drug therapy*; D000563:Amebicides / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D000818:Animals; D001152:Arsenicals / Q000627:therapeutic use; D001600:Berberine Alkaloids / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D001794:Blood Pressure / Q000187:drug effects; D007464:Clioquinol / Q000627:therapeutic use; D004285:Dogs; D004404:Dysentery, Amebic / Q000188:drug therapy; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D007422:Intestines / Q000187:drug effects; D007928:Lethal Dose 50; D009119:Muscle Contraction / Q000187:drug effects; D009132:Muscles / Q000187:drug effects; D010276:Parasympatholytics / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology; D011817:Rabbits; D051381:Rats
D000563:Amebicides; D001152:Arsenicals; D001600:Berberine Alkaloids; D006993:Hypnotics and Sedatives; D010276:Parasympatholytics; D010277:Parasympathomimetics; D007464:Clioquinol